Skip to main content

Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.

Hardwoods Distribution Inc. (HDI-T) announced it has purchased Far West Plywood for a total value of US$3.6-million. Far West is a single site wholesale distributor located in Northridge, Cal., with estimated annual sales of US$12-million.

"The addition of Far West represents a contiguous expansion of our current southern California operations and provides additional size and scale in an attractive growth market," stated HDI CEO Rob Brown.

Story continues below advertisement

**

Drone Delivery Canada (FLT-X) announced it has submitted its expression of interest to participate in Transport Canada’s National Trade Corridors Fund (NTCF) for a total request of $12-million to deploy DDC’s drone delivery solution in two remote locations.

"The vision of the Canadian Federal Government to modernize and improve transportation across Canada's north is consistent with DDC's commercialization strategy of servicing Canada's remote communities," stated Tony Di Benedetto, CEO. "Various government funding solutions exist to allow Canadian enterprise to help transform Canada's transportation systems. DDC looks to capitalize on this type of funding as we commercialize our Drone delivery solution in 2019.

**

National Access Cannabis Corp. (META-X) reported revenue for its first quarter ended Nov. 30 was $3.8-million, representing a 766-per-cent increase over the same period last year of $437,352. Its net comprehensive loss for the quarter was $7.9-million or 4 cents per share versus a net comprehensive loss of $1.3-million or a penny per share a year earlier.

**

Valens GroWorks Corp. (VGW-C) announced it has entered into a multi-year extraction services agreement with Organigram Inc. (OGI-T) for cannabis and hemp extraction services.

Story continues below advertisement

"Under the terms of the agreement, Valens will extract cannabis flowers and trim from Organigram's Moncton operation as well as hemp to produce extract concentrate," the company stated. "In turn, the concentrate will be used by Organigram to produce oils and, eventually, derivative edible and vaporizable cannabis products. The legalization of cannabis edibles and other derivative based products in Canada is expected later this year. In addition, under the terms of the agreement, Valens will also provide lab services for Organigram as needed."

**

HLS Therapeutics Inc. (HLS-X) announced that it has received the conditional approval of the Toronto Stock Exchange to graduate from the TSX Venture Exchange to list the company’s common shares on the TSX.

"Graduating to the TSX represents an important milestone for the company as we continue to execute on our plan to build, and grow, a leading Canadian-based North American-focused specialty pharmaceutical company," stated Greg Gubitz, CEO of HLS.

**

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter